Top 50 Medical Startup Investors in Austria in April 2025

Investor	Medical Austria investments
xista science ventures	5
xista science ventures	5
APEX Ventures	4
APEX Ventures	4
SOSV	4
MIG Capital	2
bmp Ventures	2
Rene Schneider	2
MassMutual Ventures	2
Peak Pride	2
MMC Ventures	2
Johann "Hansi" Hansmann	2
tecnet equity	2
aws Gründungsfonds	1
Aescuvest	1
RoX Health	1
LANA Ventures	1
FREE VALLEY HOLDINGS LIMITED	1
Santo Holding	1
austria Wirtschaftsservice (aws)	1
Boehringer Ingelheim Venture Fund	1
HBM Partners	1
IPO Beteiligungs-Management	1
NEOÏ S.à.r.l	1
Biopart	1
Nova Capital Management	1
West Asia Investment Partners S.a.r.l.	1
EMBL Ventures	1
eQventure	1
IT-Farm	1
Gamma Capital Partners	1
Medicus Ltd	1
MMV Europe & Asia-Pacific	1
PUSH VC	1
FCPG Affi	1
Novartis Venture Fund	1
Die Brückenköpfe	1
GLS Ventures	1
redalpine	1
Rafael Vartian	1
Crista Galli Ventures	1
IBG Beteiligungsgesellschaft Sachsen-Anhalt	1
Wellcome Trust	1
Techno Venture Management	1
Nina Capital	1
Algorithm Ltd	1
Ligand Pharmaceuticals	1
Ascend Capital Partners	1
red-stars.com	1
Arax Capital Partners	1

We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.

Investment focus

Biotechnology, Medical, Medical Device
Seed, Pre-Seed, Series A
Austria, France, Slovenia

Portfolio highlights

Syntropic — Syntropic is a medical device company that develops novel technologies that helps for the treatment of psychiatric diseases and the improvement of cognitive abilities.
G.ST Antivirals — G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
HEPHAISTOS-Pharma — Hephaistos Pharma is a developing weapons firm. They provide services for oncology, immunotherapy, and cancer. An online inquiry form is available on the company's website.

We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.

Investment focus

Biotechnology, Medical, Software
Seed, Pre-Seed, Series A
Austria, Slovenia

Portfolio highlights

subdron — subdron focuses on data processing in underwater inspections and autonomous underwater navigation.
infrared.city — Redefine environmental simulations. Our bespoke AI models revolutionise performative design, slashing time, cost, and complexity. Access cutting-edge services effortlessly because innovation should be for everyone
VALANX Biotech — Protein conjugation. Specific, fast and cost effective.

APEX Ventures is a deep-tech and medical-focused venture capital firm.

Investment focus

Artificial Intelligence, Health Care, Software
Seed, Series A, Pre-Seed
Germany, United Kingdom, Austria

Portfolio highlights

GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
HyperHeat — HyperHeat is a climate tech startup, that develops a breakthrough solution for zero-carbon industrial heat at very high temperatures.
TriLite Technologies — The world's smallest projection displays from TriLite take laser beam scanning technology to the next level, for augmented vision as light as the eyewear of today.

APEX Ventures is an early-stage venture capital fund that invests in start-ups grounded in unique and protectable technology. They provide support and resources and aims to develop their start-ups in their respective field. Their initial focus areas include digital media, business intelligence, cybersecurity, fintech, and the future of work.

Investment focus

Artificial Intelligence, Health Care, Software
Seed, Series A, Pre-Seed
Germany, United Kingdom, Austria

Portfolio highlights

Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
HyperHeat — HyperHeat is a climate tech startup, that develops a breakthrough solution for zero-carbon industrial heat at very high temperatures.

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Investment focus

Biotechnology, Health Care, Software
Seed, Convertible Note, Pre-Seed
United States, India, United Kingdom

Portfolio highlights

MixRift — MIXRIFT - game developers specialized in Mixed Reality
unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.

Zusammen gestalten wir die Unternehmen von morgen.

Investment focus

Biotechnology, Health Care, Medical
Series A, Funding Round, Series B
Germany, France, Austria

Portfolio highlights

Inbolt — InBolt has developed the world’s smallest and most efficient 3D camera tracking system. Their first product is a hardware module / device that an operator can plug onto all manual tools such as a drill, a screwdriver or a torque wrench. Once on the tool, it guides the operator, validates the completion of a task in real time and registers allthe completion parameters.
SciRhom — SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academicand industry scientists with profound experience in antibody development.
Innatera — Innatera is a Dutch nanotech company and an offspring of the Delft University of Technology in the Netherlands.

bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.

Investment focus

Information Technology, Software, Manufacturing
Seed, Funding Round, Series A
Germany, United States, Austria

Portfolio highlights

Livil — Livil provides a toolkit for designing and delivering flexible employee benefits, including lifestyle, dental, and vision plans.
RAYDIAX — We are Raydiax.Interventional only.Our goal is to reinvent computer tomography that is focussed on treatment.
XenoPatch GmbH — First-ever portable device for pain management, seamlessly combines heat, cold and vibration treatment with an intuitive smartphone app.

Rene Schneider

Investment focus

Medical, Analytics, Health Diagnostics
Seed, Series A
Austria

Portfolio highlights

Medicus AI — Medicus AI is an innovative technology company that supports you by offering an AI-powered experience that takes your business to the next level and provides your patients with personalized access to better understand and manage their health

MMV is a multistage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health companies. We help accelerate the growth of the companies we partner with by providing capital, connections and advice.

Investment focus

Software, Financial Services, Information Technology
Series A, Series B, Seed
United States, India, Singapore

Portfolio highlights

H2SITE — We provide fully integrated systems to produce on-site high quality hydrogen.
Sunairio — Sunairio is a developer of a weather intelligence platform for renewable energy prediction. Its platform offers simulations that account for correlations between multiple locations and weather features and leverages the complete NOAA sub-hourly historical archive.
Dune Security — AI fighting AI.CISOs face an impossible risk landscape today. 80% of cybersecurity breaches start because of employee error. The problem is exacerbating with generative AI, as a single hacker can specifically target thousands of employees in the same amount of time that they used to specifically target tens of employees with social engineering.CISOs lack tools to deal with employee risk and are held accountable when a breach inevitably happens.By leveraging AI at each step, Dune Security empowers organizations to quantify individual risk through analyzing user behavior, context, learning patterns, and third party data. This allows the automation of tailored cybersecurity measures to each individual, transforming vulnerabilities into strengths. Dune is the central engine of all employee risk data, which is a solution that is not just timely for organizations but necessary in navigating the present cybersecurity landscape. This gives the CISO the capability to understand who are the high risk employees, to what extent, and why - as well as automatically remediate and restrict access to keep their organization safe.Today, Dune Security uniquely replaces legacy and ineffective security awareness training by pinpointing the crucial 8% of employees responsible for 80% of the risk, ensuring all employees receive personalized, machine learning-driven training tailored to their risk profile. CISOs also have easy access to quantifiable data via robust reporting and API-out capability, enabling them to both report to compliance auditors, regulators, and insurance underwriters, as well as restrict access to high-risk employees through other security systems.

Multi family office investing in proptech, digital health & sustainability

Investment focus

Health Care, Artificial Intelligence, Medical
Seed, Series A, Pre-Seed
Austria, Germany

Portfolio highlights

Greenpass — Greenpass is a ClimateTech company providing the official greenpass for climate proof real estate. Build resilience and manage climate-proof assets and portfolios in line with ESG regulations while maximizing return on invest and value with ease.
Kranus Health — Kranus Health is a global provider for Men‘s Health Prescription Digital Therapeutics (PDTs). Our therapies make millions of men live a better and longer life and enable doctors to treat their patients more efficiently.
HelloBello — HelloBello offers freshly cooked and cooled delivered human-grade food tailored to each dog’s nutritional needs. HelloBello is a PetTech company with a strong focus on the German speaking markets (for now). HelloBello’s personalized meals are free of any by-products and are portioned, packaged, and delivered directly to your door. By working with aspecialized veterinarian, HelloBello is able to derive each dog’s exact nutritional needs based on a proprietary algorithm. The recipes are made of natural sources like millet and seaweed, instead of heavy use of supplements, which makes it easier for the dog to absorb and get true nutritional benefits.Our credo in German is " ... Frisch. Individuell. Geliefert. - Frischfutter ist einfach besser ..."

MMC is a venture capital fund investing in early stage, high-growth UK companies. Investing in technology companies at Seed and Series A.

Investment focus

Software, Artificial Intelligence, Machine Learning
Series A, Seed, Series B
United Kingdom, United States, France

Portfolio highlights

BlackWall — Protect your web site from hacking, content theft, crawling, and cloning!
ABEX — ABEX Capital focuses on algorithmic trading for digital assets using machine learning and high-frequency trading engines. It offers "Algorithmic Best Execution" solutions for institutional clients and is registered with the FCA for cryptoasset activities
Cloudsmith — Cloudsmith is the only universal, cloud-native solution for software artifact management and software supply chain security. Start your free trial today.

Dr. Johann ‘Hansi’ Hansmann was born in Austria and studied economics in Vienna. He spent the major part of his professional life working as an executive in the pharmaceutical industry in Austria, Germany, UK and Spain. He gathered several years of entrepreneurial experience running successfully his own pharmaceutical company in Spain afterconducting a management buy-out of a big pharmaceutical plant, making an exit in 2003. Since this time he is active as investor and business angel. He currently holds investments with a geographical focus on Austria, Germany, UK and Spain both internet and in the health industry. He led Runtastic, shpock, mysugr and just recently durchblicker and Busuu to extraordinary exits. He was president of the ‘Austrian Angels Investors Association’ until 2021, was awarded 'Best European Early Stage Investor' in 2016 by eban.org and is now based in Vienna and tries to find spare time to ride his mountain bike.

Investment focus

Software, Health Care, Fitness
Seed, Angel, Pre-Seed
Austria, United Kingdom, Spain

Portfolio highlights

fynk — Create, edit, negotiate and sign contracts quickly with fynk. Give your team back valuable time. Test it now for free!
Balun — Balun is a machine learning platform that forecasts electricity generation with unrivaled precision by analyzing multiple meteorological and energy market inputs, allowing renewable energy producers to optimize production, reduce penalties, and assure a stable, efficient grid.
Shopstory — boomerank is a SaaS that helps eCommerce companies grow automatically with help of a powerful AI and the creation of an immense data hub.

tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.

Investment focus

Software, SaaS, Information Technology
Seed, Funding Round, Series A
Austria

Portfolio highlights

Sipfront — Sipfront helps telecom operators to deliver better services by automating 24/7 active monitoring and by providing a test framework to simulate customer calls at scale
Orderlion — Streamline your wholesale business with Orderlion's ordering app. Automate orders, boost sales, and enhance customer loyalty. Find out more!
VALANX Biotech — Protein conjugation. Specific, fast and cost effective.

aws Gründerfonds is Austria's 70m venture capital fund. We invest as co-investor in Austrian high-growth start-ups in their later seed and (pre-)series-A stages.

Investment focus

Software, SaaS, Information Technology
Seed, Series A, Funding Round
Austria, United States, Germany

Portfolio highlights

Tree.ly — Tree.ly enables forest owners to generate additional income. Companies can buy high-quality carbon credits.
Greenpass — Greenpass is a ClimateTech company providing the official greenpass for climate proof real estate. Build resilience and manage climate-proof assets and portfolios in line with ESG regulations while maximizing return on invest and value with ease.
HelloBello — HelloBello offers freshly cooked and cooled delivered human-grade food tailored to each dog’s nutritional needs. HelloBello is a PetTech company with a strong focus on the German speaking markets (for now). HelloBello’s personalized meals are free of any by-products and are portioned, packaged, and delivered directly to your door. By working with aspecialized veterinarian, HelloBello is able to derive each dog’s exact nutritional needs based on a proprietary algorithm. The recipes are made of natural sources like millet and seaweed, instead of heavy use of supplements, which makes it easier for the dog to absorb and get true nutritional benefits.Our credo in German is " ... Frisch. Individuell. Geliefert. - Frischfutter ist einfach besser ..."

Aescuvest’s mission is to facilitate and enable impactful investments into medical breakthrough innovation to disrupt and improve healthcare delivery models, products, and services. Aescuvest enables its investors to build their very individual portfolio of healthcare start-ups - according to their personal investment focus. A cooperation with EITHealth, and a growing network of partnerships across Europe, allow Aescuvest to source and evaluate the most promising healthcare investment opportunities, structure their financing rounds, and enable healthcare technology-driven investors, such as Business Angels, HNWIs, Family Offices, and Corporate Investors, to participate in healthcare investment opportunities by direct investments via SPV structures. The Investment Committee, composed of Aescuvest’s very own investment team and members of tthe Advisory Board of Aescuvest, both deeply rooted in the healthcare industry and with proven track records, have developed a strong and over the last years well tested, pre-screening and due diligence process, to identify and select healthcare start-ups. Aescuvest’’s Management (circle of General Partners) put their ‘skin’ into each investment by committing capital to each company prior introduction to the wider Aescuvest investor base. The combination of innovative ways for equity capital provision, with healthcare industry and investment expertise, provides the Aescuvest portfolio companies a unique platform to develop their business solution, accelerate their path towards commercialization, and lower market access barriers.

Investment focus

Health Care, Medical, Biotechnology
Equity Crowdfunding, Seed, Pre-Seed
Germany, The Netherlands

Portfolio highlights

XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
Lillian Care — Lillian is building a nationwide network of health facilities in Germany.
piur imaging — PIUR´s tomographic ultrasound solutions turn any standard ultrasound system into a tomographic 3D imaging device, bridging the gap between 2D ultrasound and regular tomographic imaging modalities. With any conventional 2D ultrasound transducer, high-resolution tomographic images can be generated and stored as quantifiable volumes, enabling true AIpost-processing for efficient diagnostics. Current focus is on thyroid imaging where AI algorithms allow doctors a fast and objective analysis and classification of thyroid nodules.

Hello, our name is ROXand we are taking digital healthcare to the streets.

Investment focus

Health Care, Health Diagnostics, Apps
Pre-Seed, Seed
Germany, Austria

Portfolio highlights

XUND — Answer the most important health questions with AI-powered technology from XUND. Medically certified and CE marked.
Halitus — Laser Technology x Gas Dynamics Analysis x Machine Learning.
MindAhead — Digital Health, Med Tech, Brain Health

LANA Ventures is a venture capital firm.

Investment focus

Apps, Medical, mHealth
Seed
Austria

Portfolio highlights

XUND — Answer the most important health questions with AI-powered technology from XUND. Medically certified and CE marked.

Investment Company

Investment focus

Medical, Analytics, Health Diagnostics
Series A
Austria

Portfolio highlights

Medicus AI — Medicus AI is an innovative technology company that supports you by offering an AI-powered experience that takes your business to the next level and provides your patients with personalized access to better understand and manage their health

Santo Holding is a Zurich-based investment firm funding biotechnology, pharmaceutical, life sciences, and healthcare companies.

Investment focus

Biotechnology, Energy, Medical
Funding Round, Series B, Series C
Germany, Austria

Portfolio highlights

AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
SuppreMol — SuppreMol is a privately held biotechnology company that pioneers a novel approach for the treatment of autoimmune diseases which could lead to the cure of these disorders instead of merely treating their symptoms.
Efficient Energy — Efficient Energy GmbH is an innovative manufacturer and system supplier of environmentally friendly refrigeration technology, based in Feldkirchen near Munich, Germany. The company developed the Bluezero-technology, which uses water as a refrigerant and and thereby entirely avoids fluorinated refrigerants (HFCs). Efficient Energy helps itscustomers overcome the increasing regulatory challenges of refrigeration technology, and offers them long-term, sustainable solutions with its eChiller model range. The eChiller chilled water units are ideally suited for process cooling, machine cooling and the cooling of technical equipment and data centres and provide cooling capacities from 35 kW to 120 kW, depending on the model. With its outstanding cost efficiency and low CO2 footprint, companies benefit on many fronts. The pioneering technology has also been noticed by politics and the media, and has received multiple awards for the eChiller. These include among others the European Business Award for the Environment 2018/2019 from the European Comission and the Red Herring Europe Top 100 in 2020.

The Austrian Economic Service mbH (aws) is the promotional bank of the Federal Government.The aws SME fund is the largest Austrian Fund for silent corporate investments, but also providers of equity. Founded in late 2009 by the Austrian Economic Service mbH (aws) - the Development Bank of the Federal - he has a term until 31/12/2025.The fund is currently endowed with EUR 80 million and participates in medium-sized companies and brings with it a fresh capital to develop new products or processes, for sales development to international expansion.

Investment focus

Software, Information Technology, Biotechnology
Seed, Grant, Pre-Seed
Austria, Belgium

Portfolio highlights

HD Immune — HD Immune develops an antibody to target the mutated protein and remove it from the body. HDI has a lead antibody mAB C6-17 which lowers mtHTT in the blood and organs.
Aitiologic — aitiologic is an Austrian precision medicine startup developing ai-powered solutions for early disease detection and targeted therapy.
revitalyze — revitalyze - AI Assistant for Construction

Boehringer Ingelheim Venture Fund intends to invest in groundbreaking therapeutic approaches and technologies.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Seed
United States, Germany, Belgium

Portfolio highlights

Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
Aignostics — Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of preciseheatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis.The company was founded in 2018 and is headquartered in Berlin, Germany.
Asgard Therapeutics — Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biologicalproperties of professional antigen-presenting cells.

HBM Partners focuses on venture, growth and buy-out financings of private companies as well as investments in public companies.The HBM funds invest in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. Their team supports the growth of the portfolio companies through allstages of development, focusing on adding value by leveraging its experience and HBM's world-wide network in the industry. Investments usually range between $5 million to $50 million.

Investment focus

Biotechnology, Medical, Health Care
Series B, Funding Round, Series C
United States, Germany, Switzerland

Portfolio highlights

Dren Bio — Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.
Neuron23 — Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
Mineralys Therapeutics — Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company founded by Catalys Pacific committed to developing best-in-class, novel therapy for the treatment of hypertension. The Company is driven to bring a targeted approach to the management of hypertension via the development of MLS-101. MLS-101, licensed from MitsubishiTanabe Pharma Corporation, is a highly selective and potent aldosterone synthase inhibitor that is being investigated for the treatment of hypertension.

IPO Beteiligungs-Management is a private equity company specialized in early stage venture investments.

Investment focus

Sensor, Medical, Wireless
Series B, Funding Round
Austria

Portfolio highlights

SensorDynamics — SensorDynamics was a European semiconductor and MEMS company specialized in developing and manufacturing high-volume micro- and wireless semiconductor sensor products for applications in automotive, industry and high-end consumer sectors. The company was acquired by Maxim Integrated in 2011 for $164 million. SensorDynamics developed and producedcustom-made designs and standard components for use in vehicle stabilization, occupant protection, navigation systems, keyless go systems and autonomous energy generators for wireless and battery free controllers for industrial, automotive and high-end consumer application.[5] With its headquarters in Graz, Austria, SensorDynamics had offices in Italy and Germany and a worldwide sales and distribution network. The company employed about 130 people in 2011.
EUCODIS Bioscience — EUCODIS Bioscience is an experienced enzyme engineering company, providing industrial customers with high-performing enzymes. Their customers are leaders in the chemical, the pharmaceutical, the food and feed and cosmetics industries.

Investment Company

Investment focus

Medical, Analytics, Health Diagnostics
Series A
Austria

Portfolio highlights

Medicus AI — Medicus AI is an innovative technology company that supports you by offering an AI-powered experience that takes your business to the next level and provides your patients with personalized access to better understand and manage their health

Biopart

Investment focus

Medical, Analytics, Health Diagnostics
Series A
Austria

Portfolio highlights

Medicus AI — Medicus AI is an innovative technology company that supports you by offering an AI-powered experience that takes your business to the next level and provides your patients with personalized access to better understand and manage their health

The typical market transaction involves the sale of one company at a time. However, there are situations where disposing of holdings in a number of businesses, in a single transaction, brings significant benefits - together with substantial time and cost efficiencies.Whether seeking a solution to illiquidity, the disposal of legacy assets orthe freedom to implement strategic change, Nova offers the corporate and financial sellers an efficient and market value solution. Unlocked from their holdings, investors and owners are better positioned to focus on the benefits and opportunities this significant step change brings.Although principally an acquirer, Nova can also work with investors in private equity funds, where there is the need for a Replacement Manager or General Partner.

Investment focus

Software, Artificial Intelligence, Automotive
Seed, Series A, Series C
Italy, Poland, Austria

Portfolio highlights

Roboze — Roboze is able to engineer high performance thermoplastic polymers resistant to the most extreme operating conditions for various sectors.
contextflow — contextflow revolutionizes the medical information search process with the help of deep learning: our 3D image-based search engine for radiologists looks for regions of interest within images (currently 18+ patterns in lung CTs); when a suspicious pattern is detected, we immediately find visually similar cases, descriptions and relevant referenceinformation, affording doctors easy access to knowledge currently hidden in large medical image data and their associated reports...all within seconds. No more paging through books, guessing the right keyword or consulting various text-based reference search engines. In addition, our software can be configured to allow for prioritization of cases where patterns of interest are detected.contextflow is a spin-off of the Medical University of Vienna (MUW), Technical University of Vienna (TU) and European research project KHRESMOI. Founded by a team of AI and engineering experts in July 2016, the company was awarded the distinction of Most Promising Startup by the BCS Search Industry, received the Digital Innovation Award by the Austrian Federal Ministry of Education, Science and Research and was selected as one of 19 startups out of over 700 applications to participate in the Philips HealthWorks accelerator program. It is currently testing its 3D image-based software with six partners, expanding internationally to other locations later this year.
Cardiomatics — Cardiomatics is a cloud AI tool for ECG analysis.Simply give us a raw ECG signal and our algorithms will turn it into valuable analysis.

Investment Company

Investment focus

Medical, Analytics, Health Diagnostics
Series A
Austria

Portfolio highlights

Medicus AI — Medicus AI is an innovative technology company that supports you by offering an AI-powered experience that takes your business to the next level and provides your patients with personalized access to better understand and manage their health

EMBL Ventures invest throughout Europe with the aim to build companies that create significant commercial opportunities based on new therapeutic treatment.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
Germany, Austria, Ireland

Portfolio highlights

Arsanis — Arsanis is a clinical-stage biopharmaceutical company focused on applying monoclonal antibody (mAb) immunotherapies to address serious infectious diseases. A deep understanding of the pathogenesis of infection, paired with access to some of the most advanced mAb discovery techniques and platforms available today, has positioned Arsanis to build andadvance a pipeline of novel mAbs with multiple mechanisms of action and high potency against their intended targets.The company’s lead clinical program, ASN100, is aimed at serious Staphylococcus aureus infections and is being evaluated in Phase 2 clinical trial for the prevention of S. aureus pneumonia in high-risk, mechanically ventilated patients. In addition to ASN100, its preclinical pipeline is comprised of mAbs targeting multiple serious bacterial and viral pathogens, including respiratory syncytial virus.Arsanis is a U.S. company headquartered in Waltham, Massachusetts, with European research and preclinical development operations headquartered in Vienna, Austria (Arsanis Biosciences GmbH).
Topas Therapeutics — Topas Therapeutics GmbH is a private Hamburg, Germany-based biotechnology company focused on developing products to address areas of major unmet need, including autoimmune diseases, allergies and anti-drug antibodies. The Topas Particle Conjugates technology platform induces antigen-specific immune tolerance by harnessing the liver’s naturalimmunology capabilities. The Company has several proprietary programs; lead product candidate TPM203 has recently entered clinical testing for pemphigus vulgaris, an orphan disease. Other programs are in anti-drug antibodies, celiac disease, Type 1 diabetes, as well as a multiple sclerosis program that is available for partnering.Topas has a research and option agreement with Eli Lilly and Company focused on antigen-specific tolerance induction and a multi-year agreement with Boehringer Ingelheim to collaborate in the field of anti-drug antibodies.Topas’ investors include: Epidarex Capital, Gimv, EMBL Ventures, Evotec and Boehringer Ingelheim Venture Fund.
Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.

Entrepreneurs for Entrepreneurs

Investment focus

Software, Information Technology, Artificial Intelligence
Series A, Seed, Series B
Austria, Switzerland

Portfolio highlights

Finmatics — Finmatics is a self-learning, artificial intelligence system that automates the activities of accounting service providers. It adapts itself to the unique bookkeeping requirements of companies, industries, and countries by analyzing the activities of human accountants.
Greenwood-Power — Greenwood-Power is the leading innovator for non-conventional transformers. Let's talk about your individual requirements - CONTACT US TODAY!
Autonoma Technologies — Autonoma Technologies is an information technology company that specializes in the digitalization of customer platforms.

IT-Farm is a venture capital firm which specializes in seed, start-up, and early stage companies. It primarily invests in mobile, big-data, connected car, IoT, OTT service, Helth care, Bio Tech and other IT industries. The firm actively invests in SF bay area and Japan, as well as other geometries including Asia and Europe. We support portfoliocompanies, especially on the partnership with Japanese enterprises.

Investment focus

Software, Health Care, Medical
Seed, Series A, Funding Round
United States, Japan, Germany

Portfolio highlights

CROSS SYNC — The company was founded in October 2019 by Dr. Takaki, a Japanese intensivist with more than 20-year experience in critical care medicine, from his strong desire of wanting to decrease preventable death and sudden changes in patient conditions while in the ICU. CROSS SYNC’s vision is to provide ICU-level medical treatment anywhere. The mission isto help and assist medical professionals utilizing the power of technology so that they can provide high-quality medical care even in an environment where there is a shortage of specialist physicians, and to ensure the best patient outcomes. As a Yokohama University certified startup, CROSS SYNC develops a variety of AI clinical assistant tools in collaboration with affiliated hospitals, the school of medicine, and the department of health data science. By delivering our AI-based platform to acute care settings all over the world, we aim to create a world without avoidable deaths and preventable acute changes for in-patients.
EMobi — EMoBi is a transportation company that provides freight transport, and electric vehicle services with reservation facilities.
Honeycomb — Honeycomb (fka Agilius) is the only place where you can buy a condo/apartment building master policy online in less than 3 minutes at a fraction of the cost! Instant, free, no hassle quotes, online everything and up to 40% savings. With all that we're bringing simplicity and transparency to the real estate insurance space for condoassociations (HOAs), building owners, property managers, and developers everywhere. This is what we do. This is all we do.

GCP Gamma Capital Partners is a private Venture Capital investment and Equity consulting firm established in 2002 (GCP Presentation 2020). We focus on dynamic technology and growth companies in Austria, Germany, Switzerland and CEE countries bordering Austria. We aim for value creation and value realization to generate superior returns for our investors and clients.

Investment focus

Mobile, iOS, Mobile Apps
Series A, Seed, Series C
Austria, Switzerland, United States

Portfolio highlights

Wikitude — Wikitude Augmented Reality empowers your iOS, Android & Smart Glasses apps with Image & Object Tracking, Instant tracking (SLAM), Geo AR, and more.
42matters AG — 42matters offers a full suite of mobile and connected TV app intelligence solutions, including APIs, file dumps, and visual, web-based platforms.
Organica Water — Organica Water is a global provider of innovative solutions for the treatment and recycling of wastewater. Over the past two decades Organica has developed a truly unique approach, enabling customers all over the world to build and operate space and energy efficient biological wastewater treatment plants (WWTPs) that blend harmoniously into urbanand residential population centers, ultimately lowering infrastructure costs and facilitating reuse and recycling of treated wastewater. Established in 1998, Organica began as a traditional wastewater design-build company focused exclusively on the Hungarian market. During the first nine years of its life the company built over 75 municipal, commercial, and industrial WWTPs using a variety of different technologies, while continually investing into R&D to futher develop its own IFAS-type solution for biological wastewater treatment. In 2007 Organica sold it's design-build business to focus exclusively on the commercialization of its own biological wastewater treatment solution on a global basis. Today, Organica is an international company operating on three different continents, and the world leader in Fixed-Bed Biofilm Activated Sludge (FBAS) technology,with more than 25 operating references all over the world, and nearly a dozen additional Organica-powered WWTPs currently under construction.

Investor

Investment focus

Medical, Analytics, Health Diagnostics
Series A
Austria

Portfolio highlights

Medicus AI — Medicus AI is an innovative technology company that supports you by offering an AI-powered experience that takes your business to the next level and provides your patients with personalized access to better understand and manage their health

MMV is a multistage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health companies. We help accelerate the growth of the companies we partner with by providing capital, connections and advice.

Investment focus

Financial Services, FinTech, Information Technology
Series A, Seed, Series B
Singapore, India, United States

Portfolio highlights

Sikoia — Streamline your decision-making with centralized customer data, comprehensive case management, and automated risk evaluation without complicated integrations.
Aspire — Multi currency business account, for start-ups & SMEs, to manage your company spends & expenses, accounts receivables & payables, invoices, bills, corporate cards & cross-border payments.
Scrut Automation — Scrut Automation makes ISO 27001, SOC 2, GDPR and PCI DSS compliance easy, with 70% less Manual effort

| Investments that move industries

Investment focus

Software, Apps, Information Technology
Seed, Series A, Funding Round
Austria, Germany, United States

Portfolio highlights

Balun — Balun is a machine learning platform that forecasts electricity generation with unrivaled precision by analyzing multiple meteorological and energy market inputs, allowing renewable energy producers to optimize production, reduce penalties, and assure a stable, efficient grid.
Podero — Podero's aim is to create software that controls energy devices, such as batteries, electric cars, and heat pumps, in order to lower CO2 emissions, create new revenue streams for utilities, and lower consumer electricity bills.Podero's objective is to make it possible to coordinate the largest fleet of devices in the world by utilizingtrade algorithms, software automation, and machine learning forecasts to move energy use to the most economical and sustainable times.
enspired — enspired is a fully digital energy trading-as-a-service company. We drive the energy transition by enabling our clients to bring flexible assets to power spot markets and capture their full value with our AI-based trading services. Our team consists of leading algorithmic traders, data scientists and technology enthusiasts who firmly believe thatthe way power is traded will soon drastically change - in our world, there is no room for trading screens and traditional optimization. All trades get executed in a fully automated fashion using advanced AI algorithms that outperform the market and monetize our client's flexibility to the fullest while supporting grid stability. Our clients include leading utilities, operators of renewables and batteries or consumption assets across Europe.

FCPG Affi

Investment focus

Medical, Biotechnology, Pharmaceutical
Funding Round
Austria

Portfolio highlights

AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.

Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.

Investment focus

Biotechnology, Health Care, Therapeutics
Series B, Series A, Series C
United States, Switzerland, United Kingdom

Portfolio highlights

Rhygaze — RhyGaze is at the forefront of developing a novel first-in-class gene therapy aimed at improving vision in patients suffering from retinal diseases.
Atalanta Therapeutics — Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases.
Alesta Therapeutics — Alesta Therapeutics pioneers innovative small molecule therapies for rare diseases, including hypophosphatasia and Charcot-Marie-Tooth

Die Brückenköpfe is a management consulting and investing firm focused on the German healthcare market.

Investment focus

Artificial Intelligence, Health Care, Life Science
Seed, Series A, Pre-Seed
Germany, Austria

Portfolio highlights

anvajo — Originally started at TU Dresden, anvajo can now look back on several years of innovative research and successful product development with uninterrupted growth. As part of the business expansion and ongoing team building, anvajo moved into its new headquarters in Dresden in January 2020. On 1300 m² practically all areas, including development,production and support functions are united under one roof.
keleya — Keleya enables women and their partners to have a safe and relaxed pregnancy, birth experience and motherhood by providing them with personalized, expert based information, workouts and nutrition plans and a matching midwife. Founded in 2017, Kelaya is headquartered in Berlin, Germany.
Recare — Recare developed a software platform for discharge management and supply control in hospitals and other medical facilities. With its B2B marketplace, Recare is trying to end the paperwork in the German healthcare system.

GLS Ventures

Investment focus

Medical, Health Care, Biotechnology
Series B, Funding Round
Austria

Portfolio highlights

Nabriva Therapeutics — Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections.

redalpine is a thesis-driven vc with deep expertise in software and science. since 2006. we believe in the power of big ideas and in empowering game changers. we don't just invest, we co-create a better tomorrow. together with you.

Investment focus

Biotechnology, Software, Health Care
Series A, Seed, Series B
Germany, Switzerland, United Kingdom

Portfolio highlights

9fin — 9fin is a leading provider of debt market intelligence and offers everything you need to analyse a credit, or win a mandate in one AI-powered platform
Apaleo — Transform your hospitality business with an open platform. Easily connect 3rd party applications to build a best-in-class tech stack for your hotel
OrthoPulse — OrthoPulse is a medical device manufacturer that produces dental care equipment, treatment control apps, and photo biomodulation solutions.

Rafael Vartian

Investment focus

Medical, Analytics, Health Diagnostics
Series A
Austria

Portfolio highlights

Medicus AI — Medicus AI is an innovative technology company that supports you by offering an AI-powered experience that takes your business to the next level and provides your patients with personalized access to better understand and manage their health

Crista Galli Ventures invests in ambitious European healthtech companies at Seed and Series A. Our deep medical expertise, powerful network and agile approach enable founders to build important, world-class healthcare businesses.

Investment focus

Health Care, Wellness, Medical
Seed, Pre-Seed, Series A
United Kingdom, United States, Sweden

Portfolio highlights

Jude — Science-backed food supplement that makes you feel empowered, not embarrassed.
Vitrue Health — At Vitrue Health, our mission is to reduce or eliminate the impact that musculoskeletal health issues have on over 40% of the population using cutting edge technology. We believe that the foundation of successful outcomes in musculoskeletal health, at every stage of the pathway, is accurate assessment. Whether it's a desk worker with early stages of neck pain or a patient having a total knee replacement, Vitrue's technology can help.
Collective Minds Radiology — Collective Minds develops and delivers a cloud-based collaboration platform for healthcare and research with access to data, human and digital expertise.

IBG Beteiligungsgesellschaft Sachsen-Anhalt is a venture capital firm makes investments in territories such as Germany and Denmark.

Investment focus

Electronics, Software, Medical Device
Funding Round, Seed, Series A
Germany, Austria

Portfolio highlights

Livil — Livil provides a toolkit for designing and delivering flexible employee benefits, including lifestyle, dental, and vision plans.
Wingfield — Wingfield develops a system intended to transform any tennis court in the world into a smart court. The system is a combination of hardware and artificial intelligence and keeps track of the score, analyzes strokes and gives personal feedback right after matches or practice sessions and the system only costs a fraction of a professional system andis easily set up, enabling players to get the same game analytics as the professionals do.
Baby Sweets — Baby Sweets provides Online shop for beautiful and unusual baby clothes and accessories.Sales of own brands made in EU as well as international brands.

Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Grant, Series C, Funding Round
United States, United Kingdom, Germany

Portfolio highlights

RenBio — RenBio develops antibody-based therapeutic solutions for the treatment of cancer and inflammatory diseases. RenBio's proprietary MYO technology involves in the development of antibody therapeutic that helps in treating rare diseases, viral infections, autoimmune diseases, and more by using DNA blueprint and antibody factory.
Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
Feinstein Institute for Medical Research — Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes ofbehavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.

Techno Venture Management is a venture capital and private equity firm focused on healthcare industry.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Funding Round, Series B, Series A
United States, Germany, United Kingdom

Portfolio highlights

Streaming21 — Checkout the full domain details of Streaming21.com. Click Buy Now to instantly start the transaction or Make an offer to the seller!
Helomics — Helomics® is a comprehensive personalized healthcare company, bringing the next generation of diagnostics to the oncology field. Helomics is dedicated to improving patient outcomes by providing a personalized comprehensive tumor profile utilizing a proprietary set of laboratory platforms that leverage both tissue-based live and fixed cellular basedanalysis allowing physicians to characterize malignant tumors on a personalized basis. Helomics’ novel molecular and cellular markers and bioinformatics services support treatment decisions by providing vital information based on the specific biological processes of each individual’s cancer.
Precision Therapeutics — Precision Therapeutics is a pharmaceutical research and development business that develops personalized cancer treatments for patients.

We deploy early stage capital to fuel the growth of need-driven health technology companies.

Investment focus

Health Care, Artificial Intelligence, Software
Seed, Pre-Seed, Series A
United States, United Kingdom, Austria

Portfolio highlights

Noah Labs — Noah Labs is a compant that creates AI-powered software solutions for medical care and research that help diagnose, manage illnesses, and guide interventions.
Sonar — Sonar is a scalable mental health platform for schools. We use a combination of AI and human connection to ensure every student is seen and supported. For educators, Sonar offers actionable insights to improve mental wellbeing, empower your staff, and boost student outcomes.
Lillian Care — Lillian is building a nationwide network of health facilities in Germany.

Investment Company

Investment focus

Medical, Analytics, Health Diagnostics
Series A
Austria

Portfolio highlights

Medicus AI — Medicus AI is an innovative technology company that supports you by offering an AI-powered experience that takes your business to the next level and provides your patients with personalized access to better understand and manage their health

A genetic medicines company developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.

Investment focus

Health Care, Biotechnology, Medical
Corporate Round, Post-IPO Debt, Series A
United States, Austria

Portfolio highlights

Novan — Pelthos Therapeutics is a specialty bio-pharmaceutical organization committed to commercializing innovative, safe, and efficacious therapeutic products to help patients with unmet treatment burdens.
Agenus — Our mission is to the power of the immune system to bring affordable, curative therapies to cancer patients
invIOs — invIOs is a private biotechnology company that specializes in the discovery and development of next-generation cancer therapies that empower and educate the immune system to fight cancer.

Founded by two Wall Street professionals in 2002 with the goal of making companies successful by helping them raise capital and improve their management standards. This was done by taking an active role in running these companies (at the Board level and operationally) and helping to secure strategic partnerships.Over USD 100 million in assetsgenerated from successful investments in China, and more recently in Europe. All invested funds come from our partners; no 3rd party money is managed. Since the partners are investing their own capital, they are dedicated to making their investments successful.Led by Monita Mo, one of the founders and a serial entrepreneur. Our partners have decades of experience across a wide range of industries and geographical regions. All investment partners have done business in Asia and bring an extensive network of contacts for our investments. Additionally, they have started, managed, and sold businesses and understand the challenges involved.See the need to share more developed technology to other markets, especially in China, where growth opportunities may be greater. That is why we are currently focusing on companies in Europe and other developed markets that have unique technologies that can be commercialized in their home markets, Asia, and the US.

Investment focus

Health Care, Medical Device, Internet of Things
Series A, Seed, Funding Round
Finland, Austria, United States

Portfolio highlights

piur imaging — PIUR´s tomographic ultrasound solutions turn any standard ultrasound system into a tomographic 3D imaging device, bridging the gap between 2D ultrasound and regular tomographic imaging modalities. With any conventional 2D ultrasound transducer, high-resolution tomographic images can be generated and stored as quantifiable volumes, enabling true AIpost-processing for efficient diagnostics. Current focus is on thyroid imaging where AI algorithms allow doctors a fast and objective analysis and classification of thyroid nodules.
Inflection.io — Marketing technology for product-led companies
Nanoflex Robotics — Nanoflex Robotics develops a soft robotic system that precisely inserts specially made guidewires and catheters deep into the brain. The company provides patented magnetic navigation technology but also the necessary surgical devices. Nanoflex Robotics was established in May, 2021 in Zurich, Switzerland.

red-stars.com is an operative holding company that invests in and manages companies that provide mission-critical products and offerings to enable DIGITALIZATION and LIFE SCIENCES.

Investment focus

Software, Biotechnology, Telecommunications
Funding Round, Seed
Austria, Germany

Portfolio highlights

Txture — Txture is an end-to-end cloud transformation platform for planning transformations, migration management and cloud infrastructure optimization.
a:head bio — a:head aims to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids
HeartBeat.bio — HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies.

ARAX Capital Partners is an Austrian bio-tech and high-tech early stage investor with an exclusive focus on Austrian ventures. Companies need to be young, innovative (if possible with patentable technology) and must have already secured pre-seed funding to qualify for an investment

Investment focus

Biotechnology, Health Care, Medical
Seed, Funding Round
Austria

Portfolio highlights

AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
Greenpass — Greenpass is a ClimateTech company providing the official greenpass for climate proof real estate. Build resilience and manage climate-proof assets and portfolios in line with ESG regulations while maximizing return on invest and value with ease.
Calyxha Biotechnologies GmbH — A new perspective on inflammation